Search Results for agency_names:"Agency for Healthcare Research and Quality"

The Agency for Healthcare Research and Quality (AHRQ) has announced its intent to request approval from the Office of Management and Budget for a new data collection project focused on Long COVID. This project aims to evaluate the effectiveness of the AHRQ's Long COVID Care Network, which has been set up to improve healthcare access and services for Long COVID patients, particularly those from underserved communities. The project will include interviews and surveys with healthcare providers and aims to gather insights into how well the care strategies are working and their reach. Public comments on this proposal are invited until February 18, 2025.

The Agency for Healthcare Research and Quality (AHRQ) is seeking additional scientific information from the public to assist with a systematic review on managing menopausal symptoms in perimenopausal and early postmenopausal women. This review is being conducted by AHRQ's Evidence-based Practice Centers (EPC) Program to improve its quality by considering both published and unpublished relevant studies. People and organizations are invited to submit completed and ongoing study details, which should be public or able to be made public, by April 17, 2025. The review will explore questions related to the effectiveness and safety of treatments for menopausal symptoms, as well as individual and system-level factors influencing treatment.

The Agency for Healthcare Research and Quality (AHRQ) is asking the public to submit scientific information to help with their review on the impact of healthcare worker safety and wellness. This review aims to gather evidence to understand the connections between work conditions and burnout among healthcare workers, and how this affects patient outcomes, healthcare organizations, and society. The submissions, due by January 21, 2025, should include details about relevant completed or ongoing studies. The review's findings will be shared on AHRQ's website for public comment.

The Agency for Healthcare Research and Quality (AHRQ) is requesting the public to submit scientific information about interventional treatments for acute and chronic pain. This information is needed for a systematic review being done by AHRQ's Evidence-based Practice Centers Program. They are interested in studies related to these treatments, including those that cover adverse events. Submissions must be made by February 16, 2021, and should include study details such as methodology and outcomes, but not marketing or confidential information.

The Agency for Healthcare Research and Quality (AHRQ) is seeking public input to develop measures for diagnostic excellence using data from administrative systems or electronic health records. These measures aim to identify opportunities to improve the diagnostic process on a large scale, helping to enhance healthcare quality and address diagnostic errors. AHRQ encourages feedback on the usefulness and importance of existing or new measures, especially those that are feasible, scientifically acceptable, and can identify gaps in diagnostic performance. Comments on this request must be submitted by February 13, 2025, to aid in shaping future healthcare policies and tools for better diagnostic practices.

The Agency for Healthcare Research and Quality (AHRQ), part of the Department of Health and Human Services, is requesting public submissions of scientific information about hypofractionated radiation therapy for localized prostate cancer. They aim to improve a systematic review being conducted by their Evidence-based Practice Centers. Submissions, due by February 13, 2025, should include completed and ongoing study details relevant to the topic, respecting public access and confidentiality guidelines. The review seeks to address specific questions about treatment benefits, harms, and various influencing factors.

The Agency for Healthcare Research and Quality (AHRQ) is seeking public comments on developing measures for diagnostic excellence. This initiative aims to improve the diagnostic process in healthcare settings by using data from administrative sources or electronic health records. AHRQ is particularly interested in measures that could enhance patient safety, address diagnostic errors, and provide useful benchmarks for national surveillance. They welcome feedback on existing and potential measures that can be applied across various health systems and contribute to reducing health disparities.

The Agency for Healthcare Research and Quality (AHRQ), under the Department of Health and Human Services, announced five upcoming subcommittee meetings that will handle the review and discussion of grant applications. These meetings will be closed to the public to protect confidential information. The meetings are scheduled virtually on specific dates in February 2025, focusing on topics like healthcare safety, outcomes research, system value, research training, and information technology. For more details, interested parties can contact Jenny Griffith at AHRQ.

The Agency for Healthcare Research and Quality (AHRQ) is asking the public for scientific information to help with a review of medical care for adults with Down syndrome. This request is part of the Evidence-based Practice Centers (EPC) Program's efforts to gather relevant studies, both published and unpublished, to improve the quality of their review. The deadline for submissions is January 8, 2025, and contributions should include details about completed and ongoing studies, with appropriate documentation provided. The draft review will be available for public comment and will explore questions about the benefits and harms of various medical care practices for adults with Down syndrome.

The Agency for Healthcare Research and Quality (AHRQ) will hold a Special Emphasis Panel (SEP) meeting on January 10, 2025, focused on implementing and evaluating patient-centered clinical decision support strategies in real-world settings. This meeting, which will review grant applications, is closed to the public because it may involve confidential information. The discussions could involve trade secrets or private information that cannot be shared publicly to avoid privacy violations. The meeting will take place via video review at their location in Rockville, Maryland.